Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CDC25B | P30305 | 1/20 | 0.49 |
| ▸ | CASP6 | P55212 | 1/20 | 0.49 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8951604 | 0.86 | LCK (0.56) | HSD17B10ADRA1ATAAR1MTNR1AMTNR1B | |
| SCHEMBL7802198 | 0.83 | HSD17B10 (0.49) | HSD17B10ADRA1ATAAR1ALDH1A1MTNR1A | |
| SCHEMBL8531028 | 0.82 | HSD17B10 (0.46) | HSD17B10ADRA1ATAAR1MTNR1AMTNR1B | |
| SCHEMBL7802403 | 0.81 | ALDH1A1 (0.50) | HSD17B10ALDH1A1MTNR1AMTNR1BMAPT | |
| SCHEMBL1825236 | 0.81 | MTNR1B (0.52) | HSD17B10ALDH1A1MTNR1AMTNR1BMAPT | |
| SCHEMBL29380973 | 0.78 | SMN1; SMN2 (0.59) | ALDH1A1CDC25BCASP6RCE1MAPT | |
| SCHEMBL27720018 | 0.78 | SMN1; SMN2 (0.59) | ALDH1A1CDC25BCASP6RCE1MAPT | |
| SCHEMBL221141 | 0.78 | SMN1; SMN2 (0.59) | ALDH1A1CDC25BCASP6RCE1MAPT | |
| SCHEMBL30956327 | 0.78 | MTNR1A (0.50) | HSD17B10ADRA1ATAAR1ALDH1A1MTNR1A | |
| SCHEMBL8951153 | 0.78 | MTNR1A (0.50) | HSD17B10ADRA1ATAAR1ALDH1A1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0815087-B1 | TRISUBSTITUTED PHENYL DERIVATIVES | NOVARTIS AG (CH) | 2001-11-14 | — | — | EP | disclosed |
| US-5990116-A | USE IN PREVENTION OR TREATMENT OF INFLAMMATORY AND PROLIFERATIVE SKIN DISEASES AND CANCER; COMPOUNDS SUCH AS 6-(2-(2,5-DIMETHOXYPHENYL)ETHYL)-4-ETHYL-QUINAZOLINE | NOVARTIS AG (CH) | 1999-11-23 | — | — | US | disclosed |
| EP-0815087-A1 | TRISUBSTITUTED PHENYL DERIVATIVES | Novartis AG (CH) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996028430-A1 | TRISUBSTITUTED PHENYL DERIVATIVES | NOVARTIS AG (CH) | 1996-09-19 | — | — | WO | disclosed |